Casting doubt on previous conjectures, a new study suggests that statins do not protect patients against Parkinson’s disease.
Teva Pharmaceutical Industries’ investigational drug designed to prevent chronic migraines recently demonstrated positive results in a phase 2 study.
An OTC allergy medication may be able to kill the bacteria behind Lyme disease, bringing researchers closer to developing the first targeted therapy for the debilitating infection.
Fed up with alleged unpaid overtime and missed rest periods, a Walmart pharmacist is fighting back against the retail giant with a class action suit.
Preventing exposures to blood and body fluids is critical to preventing occupationally acquired HIV.
A new FDA approval has given women seeking long-term birth control an additional option.
Heritage Pharmaceuticals Inc. is voluntarily recalling 10 lots of its 150 mg injectable colistimethate and 3 lots of its 600 mg injectable rifampin following FDA observations of aseptic practices at the manufacturer's site that could potentially affect the products’ sterility.
What do Missy Elliot and Sia Furler have in common? Graves’ disease.
Four states are reporting recent progress on preventing pseudoephedrine diversion after implementing a real-time, stop-sale tracking system.
If you suffer from migraines, you are not alone.
Various treatments for osteoarthritis can decrease pain and maintain joint mobility.
With proper treatment, individuals with atrial fibrillation can live normal and active lives.
Sore throats lasting longer than a week require medical attention.
Strategic Alliance Partners
Directions in Pharmacy
Specialty Pharmacy Times